Disclaimer. To persons visiting this web site from Europe, Asia, Africa, Australia, New Zealand, Canada or elsewhere outside the USA  
 ScyFIX MCS 700 therapy has a CE mark and is declared by the manufacturer to be a Class 2A product. This means that it is non-invasive and safe and approved for sale without a doctor's prescription. By using the device, appliances and nutritional supplements and accepting the conditions in this disclaimer, you acknowledge and agree that neither ScyFIX nor its heirs or assigns, shall be liable for any direct or indirect consequential damages to you or any other persons or property that may be exposed to the device, appliances and nutritional supplements. If so required by law in your country, you shall only use this device under the supervision of a medical professional licensed to dispense it and monitor your treatment. It is entirely the buyer's (be it a patient, a doctor or a distributor) own responsibility to establish whether the products are legal to import and use in the buyer's country.

Disclaimer. To persons visiting this web site from the USA.
In the USA federal law restricts the sale of the ScyFIX 700 device. The ScyFIX MCS 700 is not yet available for commercial sale in the USA. ScyFIX cannot and will not ship to USA addresses. US customers who mistakenly order and pay for a therapy kit over the web, will be contacted and refunded. However, ScyFIX will deduct 200 € (Euros) covering banking fees and handling costs. If you are a US resident and want to know more about our therapy, please send an inquiry by e-mail to our European office: support@scyfix.org 
By using the device, appliances and nutritional supplements and accepting the conditions in this disclaimer, you acknowledge and agree that neither ScyFIX nor its heirs or assigns, shall be liable for any direct or indirect consequential damages to you or any other persons or property that may be exposed to the device, appliances and nutritional supplements. If so required by law in your country, you shall only use this device under the supervision of a medical professional licensed to dispense it and monitor your treatment. It is entirely the buyer's (be it a patient, a doctor or a distributor) own responsibility to establish whether the products are legal to import and use in the buyer's country.

 
     

Breaking News! The ScyFIX 700 MCN Therapy is the only patented Micro Current Neuromodulation (MCN) device approved in Europe for the treatment of Retinitis Pigmentosa. Compelling Clinical Results: Retinitis Pigmentosa (RETINITIS PIGMENTOSA) and our Dry Age-Related Macular Degeneration (“ARMD”) are degenerative diseases, and improvement in visual fields, visual acuity, or contrast sensitivity is not expected. Data through twenty-four months suggests that MCN therapy is clinically effective. The data reflects that MCN therapy has not only slowed down the progression of disease symptoms as intended, but has in many cases halted, and in some cases reversed the progression of the diseases.
Patients are now using mobile phones, reading newspapers, seeing faces of family members and threading needles, none of these day to day activities were possible for these patients before using the ScyFIX MCN device. Similar compelling results have been achieved in our Dry Age-Related Macular Degeneration (“ARMD”) trial as well.